Nektar Therapeutics short interest in 2019
In 2019, Nektar Therapeutics's disclosed short interest ran from 11.40% of shares outstanding on 15 Jan 2019 to 16.71% on 31 Dec 2019, a change of +5.31 percentage points. The year's high was 19.73% on 31 Oct 2019 and its low 10.24% on 30 Apr 2019, averaging 14.10% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.89 days on 15 Jul 2019. Full history: Nektar Therapeutics.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 11.40% (15 Jan 2019)
- End of year
- 16.71% (31 Dec 2019)
- Change
- +5.31 pp
- High
- 19.73% (31 Oct 2019)
- Low
- 10.24% (30 Apr 2019)
- Average
- 14.10%
- Highest days to cover
- 19.89 (15 Jul 2019)
- SEC filings marked
- 9
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 11.40% | 7.78 | results (8-K) |
| 31 Jan 2019 | 11.51% | 13.88 | |
| 15 Feb 2019 | 11.13% | 11.63 | |
| 28 Feb 2019 | 10.71% | 10.55 | results (8-K) |
| 15 Mar 2019 | 11.35% | 10.08 | 10-K filed |
| 29 Mar 2019 | 10.43% | 11.36 | |
| 15 Apr 2019 | 10.27% | 14.84 | |
| 30 Apr 2019 | 10.24% | 9.76 | |
| 15 May 2019 | 10.41% | 10.99 | results (8-K), 10-Q filed |
| 31 May 2019 | 12.42% | 11.99 | |
| 14 Jun 2019 | 12.95% | 15.10 | |
| 28 Jun 2019 | 13.03% | 14.79 | |
| 15 Jul 2019 | 13.28% | 19.89 | |
| 31 Jul 2019 | 13.03% | 14.12 | |
| 15 Aug 2019 | 15.60% | 5.25 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 15.85% | 9.04 | |
| 13 Sep 2019 | 16.31% | 9.19 | |
| 30 Sep 2019 | 17.63% | 10.00 | |
| 15 Oct 2019 | 18.98% | 4.97 | |
| 31 Oct 2019 | 19.73% | 16.93 | |
| 15 Nov 2019 | 19.60% | 10.58 | results (8-K), 10-Q filed |
| 29 Nov 2019 | 18.32% | 9.66 | |
| 13 Dec 2019 | 17.57% | 14.76 | |
| 31 Dec 2019 | 16.71% | 18.97 |
See also: Nektar Therapeutics's full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.